Pavel Hořák

Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study

Tycho R. Tromp, Merel L. Hartgers, G. Kees Hovingh et al. · The Lancet · 2022 · 189 citations · Full text

Metabolic Syndrome, Lipid Disorder, Cardiovascular Disease +7

Cyclosporine A or intravenous cyclophosphamide for lupus nephritis: the Cyclofa-Lune study

Jakub Závada, S Sinikka Pešičková, Romana Ryšavá et al. · Lupus · 2010 · 122 citations

Clinical Utility of Selected Disease Activity Markers in Patients with Systemic Lupus Erythematosus

Pavel Hořák, Vlastimil Ščudla, Zuzana Heřmanová et al. · Clinical Rheumatology · 2001 · 55 citations

Clinical Finding, Autoimmune Disease, Systemic Lupus Erythematosus +8

Serum protein pattern associated with organ damage and lupus nephritis in systemic lupus erythematosus revealed by PEA immunoassay

Anna Petráčková, Andrea Smržová, Petr Gajdoš et al. · Clinical Proteomics · 2017 · 46 citations · Full text

C1q complement component and -antibodies reflect SLE activity and kidney involvement

Pavel Hořák, Zuzana Heřmanová, Josef Zadražil et al. · Clinical Rheumatology · 2005 · 45 citations

Immunology, C1q Complement Component, Pathology +16